PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 90 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,016,000 | -62.7% | 313,466 | -72.2% | 0.10% | -41.7% |
| Q3 2018 | $2,721,000 | -9.5% | 1,129,121 | +4.8% | 0.16% | -24.9% |
| Q2 2018 | $3,006,000 | -42.7% | 1,077,408 | -2.5% | 0.22% | -56.5% |
| Q1 2018 | $5,248,000 | -40.0% | 1,104,940 | -26.3% | 0.50% | -65.8% |
| Q4 2017 | $8,745,000 | – | 1,500,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 5,556,778 | $4,695,000 | 0.39% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $2,958,000 | 0.27% |
| HARBOURVEST PARTNERS LLC | 440,627 | $372,000 | 0.16% |
| VHCP Management III, LLC | 221,267 | $187,000 | 0.12% |
| VHCP Management II, LLC | 130,733 | $110,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 184,955 | $156,000 | 0.02% |
| Bain Capital Public Equity Management II, LLC | 202,050 | $171,000 | 0.02% |
| Kazazian Asset Management, LLC | 12,769 | $11,000 | 0.02% |
| Rock Springs Capital Management LP | 400,000 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 138,056 | $117,000 | 0.01% |